| INTRODUC TI ON
There remains some uncertainty as to the definitive thresholds of raised intracranial pressure (ICP). Much of our current understanding of ICP levels has its foundations in monitoring following traumatic brain injury, which has led to 20 mm Hg being traditionally regarded as the threshold between "high" and "low" ICP. [1] [2] [3] [4] [5] There is still a considerable lack of "Class I' evidence in this regard, and this threshold is being treated with increasing scepticism. 5, 6 In the context of trauma, raised ICP results from an acute loss of the compensatory reserve of the skull vault due to cerebral oedema.
Intracranial pressure monitoring in trauma is useful as it provides an assessment of cerebral perfusion. In contrast, chronic conditions such as idiopathic intracranial hypertension (IIH), the observed raised ICP 
O R I G I N A L A R T I C L E
Objectives: Papilloedema is a clinical manifestation of chronically raised intracranial pressure (ICP), often seen in idiopathic intracranial hypertension (IIH). However, the extent of intracranial hypertension required to produce papilloedema is not known.
We compare ICP values in IIH patients who developed papilloedema and those who did not. We aim to identify a pathological ICP threshold predictive of the development of papilloedema in IIH patients. Fisher's exact test was used to determine predictive value of ICP.
Materials and Methods

Results:
Thirty-six patients with IIH (35 F: 1M), mean age 32.5 ± 9.49 years (mean ± SD) were included. Patients with papilloedema had a mean median 24-hour ICP of 10.4 ± 5.32 mm Hg (n = 25), significantly higher than the group without papilloedema 6.31 ± 3.30 mm Hg (n = 11) (P < .05). The papilloedema group were exposed to higher pressures (10 mm Hg) for 30 minutes or more. Using 24-hour median ICP of 10 mm Hg as a minimum cut-off predictive value gives a specificity = 91%, sensitivity = 48%, PPV = 92% and NPV = 44% of detecting papilloedema.
Conclusions:
A 24-hour ICP of 10 mmHg or more is a good predictor for papilloedema and reflects a pathological threshold. The range varied widely suggesting papilloedema can occur at even lower pressures. These results are consistent with emerging evidence suggest that pathologically "high" 24 hours ICP is lower than previously quoted.
K E Y W O R D S
cerebrospinal fluid, headache, hydrocephalus, neuroophthalmology, vision and ocular movements is thought to occur due to abnormalities CSF dynamics and cerebral venous pressure. [7] [8] [9] Therefore, the application ICP thresholds used in trauma to chronic disease process is likely to be inaccurate. 
| MATERIAL S AND ME THODS
| Study design
| Inclusion criteria
Patients who underwent 24-hour ICPM and had bilateral papilloedema present on ophthalmology review.
| Exclusion criteria
Patients with primary eye disease causing papilloedema, those without a recent ophthalmology (over 1 year), patients without 24-hour ICPM and patients who had undergone radiological or surgical intervention for IIH were excluded. Patients with optic atropy were also excluded.
| Clinical examination
All patients were examined independently by an ophthalmologist. Retinal photography was used to confirm the presence of papilloedema, Snellen charts for acuity and automated kinetic perimetry (Goldmann). The Frisén method was used to categorise Median ICP (during day and night) was recorded. Intracranial pressure data were processed using Excel (Microsoft ©, Reading). All ICPM data were analysed prospectively. Intracranial pressure is presented as mm Hg (1 mm Hg = 1.36 cmH 2 O).
| Statistical tests
A paired two-tailed t-test was performed to determine whether there was a significant difference in mean (of median 24-hour)
ICPM between the papilloedema and non-papilloedema groups.
Regression analysis was performed to determine whether there was a correlation with severity of papilloedema ( 
| Ethics and consent
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Ethic committee approval was not required for this type of study. All patients provided informed consent 24-hour ICPM.
| RE SULTS
| Demographics
Thirty-six patients with IIH (35 F: 1M), mean age 32.5 ± 9.49 years (mean ± SD) were identified. There were no significant differences in gender, age, use of acetazolamide, use of continuous positive airway pressure (CPAP) therapy for sleep apnoea (a known risk factor for papilloedema), symptom duration or time till ICPM between the papilloedema and no papilloedema group (Table 1) .
| Clinical examination
Eleven patients had no papilloedema. Of the 25 patients with papil- 
| Symptomatic period
The period of time the patients reported visual symptoms did not correlate with Frisén grade (R 2 = 0.02) and had no significant deviation from zero (P = .43).
| Twenty-four-hour ICPM
Patients with papilloedema had a mean median 24-hour ICP of 10.4 ± 5.32 mm Hg (range of medians 2.7-28.3 mm Hg), significantly higher than the group without papilloedema (6.31 ± 3.30 mm Hg, range of medians 1.2-10.8 mm Hg) (P < .025) (Figure 1 ). There appears to an association with higher Frisén grade and ICP (Figure 2 ).
Regression analysis of 24-hour ICP and Frisén confirmed a positive linear correlation (R 2 = 0.16) with a significant deviation from zero (P = .02) (Figure 2 ).
| Pressure-time burden
Minute-by-minute data patients was analysed to determine the pressure-time burdens in the two groups (Figure 3 ). The papilloedema group were exposed to higher pressures (10 mm Hg) for 30 minutes or more. The group without papilloedema were exposed to pressures between 5 mm Hg to 10 mm Hg for a significant period of time (over 175 minutes), but had just a few short spikes over 10 mm Hg.
| Predictive value of ICP in papilloedema
The optimal predictive cut-off value 24-hour ICP value was found to be 10 mm Hg (likelihood ratio 5.28). Predictive values suggest pressures greater than median 24-hour ICP of 10 mm Hg or more have high specificity and positive predictive value (PPV) for papilloedema (Table 2 , P = .035). The low sensitivity and negative predictive value (NPV) are consistent with the above observation that papilloedema can occur at even lower pressures.
| Complications
There were no complications from performing the index test or ref-
erence standard in this group of patients.
| D ISCUSS I ON
Papilloedema is a known phenomenon in conditions with raised intracranial pressure (ICP). The mechanism is believed to relate to the transmission of raised ICP to the optic disc via the optic sheath that is continuous with the subarachnoid space. Chronic venous engorgement contributes to this high pressure. Persistent exposure to raised 
| Patients with papilloedema have higher ICP values than patients without
We find that patients with papilloedema have higher ICP values overall than patients who did not develop papilloedema, being 
| The pressure-time burden is greater in those with papilloedema
The finding that those with papilloedema have, on average, higher ICP over a period of 24-hour monitoring is not surprising. However, some patients with relatively low 24-hour ICPM exhibited papilloedema, whilst some without papilloedema had peaks of high pressure. Analysis of the minute-by-minute ICP data found that exposure to pressures over 10 mm Hg for 30 minutes or more was common in the papilloedema group. This suggests that exposure time (even to just relatively mild ICP) is an important factor in development of papilloedema.
Whilst the time pressure-time burden is greater in those with papilloedema, it appears that it may not affect the severity of the papilloedema. We found no relationship between duration of visual symptoms (over months) and grade of papilloedema FPG. This may reflect individual variation in compensatory mechanisms to the exposure of raised ICP.
| Papilloedema in IIH
The difference between the non-papilloedema and papilloedema groups may reflect the two previously termed groups, IIH and IIH without papilloedema (IIHWOP). The term IIHWOP is becoming increasingly unpopular, with Friedman suggesting it has been inappropriately used. Papilloedema itself may be acute or chronic, the latter being most responsible for the development of visual field defects in patients with IIH. 17 Whilst we found a wide range of symptomatic periods in patients with papilloedema, these ranged from 2 months to over 8 years and therefore are more likely to reflect chronic papilloedema.
| Re-defining "high" ICP
To date, there is no concrete evidence demonstrating "normal" ICP. This is, in part, due to simple fact that there are not enough "normal" patients who have undergone ICP monitoring. ICP is one of the few physiological parameters used in medicine that has one reference value for "high"
(20 mm Hg), regardless of whether the pathology is acute or chronic.
Our finding that an ICP of 10 mm Hg or more resulted in papilloedema leads us to conclude that this pressure is pathological when chronic. This result concurs with recent evidence, in which ICP threshold values between 10 and 17 mm Hg differentiated between favourable and unfavourable outcomes patients undergoing decompressive craniectomy.
5
The low NPV observed in our study reflects the fact that papilloedema was also observed at pressures lower than 10 mm Hg.
Therefore, whilst 10 mm Hg may be the upper-end of pathological, for some patients it was as low as 6 mm Hg. This variation may reflect individual propensity to develop papilloedema, perhaps due to anatomical susceptibility in certain patients. We stress that these values are obtained after 24-hour continuous ICPM, unlike the isolated readings obtained in head injury patients.
In 2015, Kattah and colleagues performed a similar study in patients with papilloedema using CSF pressure (CSFp) on lumbar puncture measurements. 18 
| Study strengths and limitations
This is a small case series given the rare nature of this condition in adults. The main strength of this study is the consistent and significant correlation of ICP with papilloedema. This research has the potential to inform clinicians which patients are most at risk of developing papilloedema and therefore assist with prioritising treatment for vision saving interventions. Furthermore, it contributes to the ongoing debate regarding the normal thresholds of ICP.
| Future research
This study has small numbers, and further studies with greater numbers are needed. Further detailed analysis into intraocular changes and the pulsatility elements of measured ICP are being analysed to better understand the development of pathological processes underlying papilloedema.
| Conclusion
Our results suggest that a 24-hour ICP of 10 mm Hg or more is a good predictor for papilloedema and reflects a pathological threshold. Exposure time to pressures over 10 mm Hg is an important factor in development of papilloedema. The range varied widely suggesting papilloedema can occur at even lower pressures. These results are consistent with emerging evidence suggest that pathologically "high" ICP is much lower than previously quoted.
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